Table 1. MICs of CLP-19, ampicillin, ceftazidime, erythromycin and levofloxacin against E. coli, S. aureus, A. baumannii and P. aeruginosa.
| Bacterial strains | MIC, μg/mL | |||||
|---|---|---|---|---|---|---|
| Ampicillin | Ceftazidime | Erythromycin | Levofloxacin | CLP-19 | S-LALF | |
| E. coli (ATCC 25922) | 4 | 0.25 | > 256 | 0.06 | 16 | > 256 |
| S. aureus (ATCC 29213) | 2 | 16 | 1 | 0.5 | 16 | > 256 |
| A. baumannii (ATCC 19606) | > 256 | 4 | > 256 | > 256 | 32 | > 256 |
| P. aeruginosa (ATCC 27853) | > 256 | 2 | > 256 | 4 | > 256 | > 256 |
Bacterial strains at mid-log phase (1×106/mL) were treated with increasing concentrations of antibiotic agents with incubation at 37°C for 18 h. Growth was assayed by monitoring OD620. S-LALF served as control. (n = 3).